SRPT

#1777
Sarepta Therapeutics,, Inc. Common Stock
16.76
-1.18%
Secteur:
Base:
Devise de Profit:
Range quotidien
16.76
16.76
Range Annuel
10.41
108.48
Changement quotidien
-1.18%
Changement Mensuel
-24.27%
Evolution sur 6 mois
-8.21%
Changement Annuel
-83.92%
Clôture Précédente
16.96
Open
16.76
Bid
Ask
Low
16.76
High
16.76
Volume
160
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.68 B
  • Employee 1 372
  • Founded 1980
  • CEO Douglas S. Ingram
  • Website www.sarepta.com
  • Headquarter Delaware, United States
  • FIGI BBG000BCJ161
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
51.96
Price to sales ratio
6.9
Dividends per share
—
Dividend yield %
—

Sarepta Therapeutics Inc

Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.

Nouvelles